The observed reduction in CD39+CD73+ Treg cells in the peripheral blood of patients with endometriosis offers a novel perspective on the disease's immunological dysfunction and presents an intriguing avenue for therapeutic intervention. This evidence concerns the gene NT5E and endometriosis.